Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Reexamination Certificate
2006-08-22
2006-08-22
Lukton, David (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
C530S330000, 51, 51
Reexamination Certificate
active
07094869
ABSTRACT:
The present invention comprises growth hormone releasing peptides/peptidomimetics (GHRP) capable of causing release of growth hormone from the pituitary. Compositions containing the GHRP's of this invention are used to promote growth in mammals either alone or in combination with other growth promoting compounds, especially IGF-1. In a method of this invention GHRP's in combination with IGF-1 are used to treat Type II diabetes. An exemplary compound of this invention is provided below
REFERENCES:
patent: 4223019 (1980-09-01), Momany
patent: 4223020 (1980-09-01), Momany
patent: 4223021 (1980-09-01), Momany
patent: 4224313 (1980-09-01), Zimmerman et al.
patent: 4224316 (1980-09-01), Momany
patent: 4226857 (1980-10-01), Momany
patent: 4228155 (1980-10-01), Momany
patent: 4228156 (1980-10-01), Momany
patent: 4228157 (1980-10-01), Momany
patent: 4228158 (1980-10-01), Momany
patent: 4410512 (1983-10-01), Bowers
patent: 4410513 (1983-10-01), Momany
patent: 4411890 (1983-10-01), Momany
patent: 4839344 (1989-06-01), Bowers et al.
patent: 4880777 (1989-11-01), Momany
patent: 5206235 (1993-04-01), Fisher et al.
patent: 5246920 (1993-09-01), Bercu et al.
patent: 5268360 (1993-12-01), Yoshikawa et al.
patent: 5283241 (1994-02-01), Bochis et al.
patent: 5663146 (1997-09-01), Bowers et al.
patent: 5663171 (1997-09-01), Chen et al.
patent: 5767085 (1998-06-01), Johansen et al.
patent: B-12724/95 (1995-07-01), None
patent: 18072 (1980-10-01), None
patent: 274259 (1988-07-01), None
patent: 519750 (1992-12-01), None
patent: 112112 (2000-10-01), None
patent: WO 89/07111 (1989-08-01), None
patent: WO 89/10933 (1989-11-01), None
patent: WO 92/01711 (1992-02-01), None
patent: WO 03/04081 (1993-03-01), None
patent: WO 94/08583 (1994-04-01), None
patent: WO 94/11012 (1994-05-01), None
patent: WO 94/13696 (1994-06-01), None
patent: WO 95/11029 (1995-04-01), None
patent: WO 95/13069 (1995-05-01), None
patent: WO 95/14666 (1995-06-01), None
patent: WO 95/17423 (1995-06-01), None
patent: WO 95/34311 (1995-12-01), None
patent: WO 96/10040 (1996-04-01), None
patent: WO 96/22997 (1996-08-01), None
patent: WO 99/36431 (1999-07-01), None
patent: WO 00/09537 (2000-02-01), None
Chen, Shui Tein, Journal of the Chinese Chemical Society (Taipei, Taiwan) 37(3), 299-305, 1990.
Bowers et al., “On the in Vitro and in Vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone”Endocrinology114 (5) :1537-1545 (1984).
Bowers et al., “Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormons in Vitro”Endocrinology106 (3):663-667 (1980).
Bowers, C. Y., “GH Releasing Peptides—Structure and Kinetics”J. Pediatr. Endocrinology6(1):21-31 (1993).
Deghenghi et al., “GH-Releasing Activity of Hexarelin, A New Growth Hormone Releasing Peptide, in Infant and Adult Rats”Life Sciences54(18):1321-1328 (1994).
Egorova et al., “Synthesis of shortened analogs of substance P with modification of the glutamine residue at position 6”Chemical Abstracts(abstract only) 116(11):abstract No. 106743 (1992).
Lin, Tsau-Yen et al., “Inhibition of cathepsin D by synthetic oligopeptides”Chemical Abstracts(abstract only) 92(1):abstract No. 2280 (1980).
Lin, Tsau-Yen et al., “Inhibition of Cathepsin D by Synthetic Oligopeptides”Journal of Biological Chemistry254(23):11875-11883 (1979).
Momany et al., “Conformational energy studies and in Vitro and in Vivo activity data on growth hormone-releasing peptides”Endocrinology114(5):1531-1536 (1984).
Momany et al., “Design, synthesis and biological activity of peptides which release growth hormone in Vitro”Endocrinology108(1):31-39 (1981).
Schoen et al., “Growth Hormone Secretagogues”Annual Reports in Medicinal Chemistry: Section IV-Immunology, Endocrinology&Metabolic Diseases, William K. Hagmann, Chapter 19, vol. 28:177-186 (1993).
Schoen, W.R. et al., “Structure-activity relationships in the amino acid sidechain of L-692,429”Bioorg&Medicinal Chem. Lett. 4(9):1117-1122 (1994).
Smith. R.G. et al., “A nonpeptidyl growth hormone secretagogue”Science260:1640-1643 (1993).
Stavropoulos et al., “Synthesis of potent agonists of Substance P by replacement of Metil with Glu(OBzl) and N-terminal glutamine with Glp of the C-terminal hexapeptide and heptapeptide of Substance P”Int. J. Peptide Protein Res. 45(6):508-513 (1995).
Wu, Danxing et al., “The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist”J. of Endocrinology, 148:R9-R13 (1994).
Burnier John P.
Clark Ross G.
Elias Kathleen A.
McDowell Robert S.
Rawson Thomas E.
Evans David W
Genentech Inc.
Lukton David
LandOfFree
Low molecular weight peptidomimetic growth hormone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low molecular weight peptidomimetic growth hormone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low molecular weight peptidomimetic growth hormone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3656810